Switching from Reference Medicines to Biosimilars
Recorded on July 12, 2018
Sponsored by Sandoz (A Novartis Division)
In this webinar, Dr. Cohen will discuss a systematic literature review that was conducted of switching studies to biosimilars from their corresponding reference medicines. Primary data from 90 studies that enrolled 14,225 unique individuals was evaluated. These studies included seven different molecules that were used to treat 14 diseases. Details of reported clinical outcomes including efficacy, safety and immunogenicity will be discussed.
Hillel P. Cohen, PhD
Executive Director, Scientific Affairs
Sandoz, Inc. (a Novartis division)
This webinar is sponsored, developed and presented by the sponsor. The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy.